EX-5.1 2 tm2219374d1_ex5-1.htm EXHIBIT 5.1

 

Exhibit 5.1

 

Arthur Cox LLP
Ten Earlsfort Terrace
Dublin 2
D02 T380
 
+353 1 920 1000
dublin@arthurcox.com
dx: 27 dublin
 
Dublin
Belfast
London
New York
San Francisco
 
arthurcox.com

 

1 July 2022

 

To: Board of Directors

Mallinckrodt plc

College Business & Technology Park

Cruiserath

Blanchardstown

Dublin 15

Ireland

 

Re: Mallinckrodt plc - Form S-8 Registration Statement

 

Dear Sirs,

 

1.Basis of Opinion

 

We are acting as Irish counsel to Mallinckrodt plc, registered number 522227, a public company limited by shares, incorporated under the laws of Ireland, with its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland (the “Company”), in connection with the registration statement on Form S-8 (the “Registration Statement”), to be filed with the United States Securities and Exchange Commission (the “SEC”) on 1 July 2022 under the Securities Act of 1933, as amended (the “Securities Act”) with respect to ordinary shares with a nominal value of US$0.01 per share of the Company (the “Shares”) that may be delivered pursuant to the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the “Plan”).

 

1.1This Opinion is confined to and given in all respects on the basis of the laws of Ireland (meaning Ireland exclusive of Northern Ireland) in force as at the date hereof as currently applied by the courts of Ireland. We have made no investigation of and we express no opinion as to the laws of any other jurisdiction or the effect thereof. This Opinion speaks only as of its date.

 

1.2This Opinion is also strictly confined to the matters expressly stated herein at paragraph 2 below and is not to be read as extending by implication or otherwise to any other matter.

 

Grainne Hennessy · Séamus Given · Caroline Devlin · Sarah Cunniff · Elizabeth Bothwell · William Day · Andrew Lenny · Orla O’Connor (Chair) · Brian O’Gorman Mark Saunders · John Matson · Kevin Murphy · Cormac Kissane · Kevin Langford · Eve Mulconry · Philip Smith · Kenneth Egan · Alex McLean · Glenn Butt · Niav O’Higgins Fintan Clancy · Rob Corbet · Ultan Shannon · Dr Thomas B Courtney · Aaron Boyle · Rachel Hussey · Colin Kavanagh · Kevin Lynch · Geoff Moore (Managing Partner) Chris McLaughlin · Maura McLaughlin · Joanelle O’Cleirigh · Richard Willis · Deirdre Barrett · Cian Beecher · Ailish Finnerty · Robert Cain · Connor Manning · Keith Smith John Donald · Dara Harrington · David Molloy · Stephen Ranalow · Gavin Woods · Simon Hannigan · Niamh Quinn · Colin Rooney · Aiden Small · Phil Cody · Karen Killoran Richard Ryan · Danielle Conaghan · Brian O’Rourke · Cian McCourt · Louise O’Byrne · Michael Twomey · Cormac Commins · Tara O’Reilly · Michael Coyle · Darragh Geraghty Patrick Horan · Maeve Moran · Deirdre O’Mahony · Deirdre Sheehan · Ian Dillon · Matthew Dunn · David Kilty · Siobhán McBean · Conor McCarthy · Olivia Mullooly Laura Cunningham · Mairéad Duncan-Jones · Ryan Ferry · Imelda Shiels · Brendan Wallace · Ruth Lillis · Sarah McCague · Niamh McGovern · Ciara Buckley · Ian Duffy Sophie Frederix · Orlaith Kane · Aisling Kelly · David Vos

 

 

 

 

 

 

1.3As Irish counsel to the Company in connection with the registration of the Shares, we have examined:

 

(a)the documents listed in the schedule (the “Schedule”) to this opinion (the “Documents”);

 

(b)the searches listed at paragraph 1.5 below; and

 

(c)such other documents and records as we have deemed necessary to enable us to render the opinions set forth below.

 

We express no opinion, and make no representation or warranty, as to any matter of fact or in respect of any documents which may exist in relation to the Plan other than the Documents.

 

1.4In giving this Opinion, we have examined and relied on copies of the Documents sent to us by email in pdf or other electronic format.

 

1.5For the purpose of giving this Opinion, we have caused to be made the following legal searches against the Company on 1 July 2022:

 

(a)on the file of the Company maintained by the Irish Registrar of Companies in Dublin for mortgages, debentures or similar charges or notices thereof and for the appointment of any receiver, examiner or liquidator;

 

(b)in the Judgments Office of the High Court of Ireland for unsatisfied judgments, orders, decrees and the like for the twelve years immediately preceding the date of the search; and

 

(c)in the Central Office of the High Court in Dublin for any proceedings and petitions filed in respect of the Company.

 

2.Opinion

 

Subject to the assumptions set out in this Opinion and to any matters not disclosed to us, we are of the opinion that:

 

2.1the Company is a public company limited by shares and is duly incorporated and validly existing under the laws of Ireland; and

 

2.2when the Shares have been issued pursuant to and in accordance with the terms and conditions referred to or summarised in the Plan, the Shares will be validly issued, fully paid up and non-assessable (which term means when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such shares).

 

3.Assumptions

 

For the purpose of giving this Opinion, we assume the following without any responsibility on our part if any assumption proves to have been untrue as we have not verified independently any assumption:

 

Constitution

 

3.1that the joint plan of reorganization relating to the Company under Chapter 11 of the US Bankruptcy Code and the scheme of arrangement confirmed pursuant to an Irish High Court order (the “Scheme”) following the Company's examinership proceedings under Part 10 of the Companies Act 2014 (the “Act”) have become effective, as a consequence of which the Constitution of the Company appended to the Scheme is in effect (the “Constitution”);

 

Page 2

 

 

 

 

Registration Statement and the Plan

 

3.2that when filed with the SEC, the Registration Statement will not differ in any material respect from the drafts that we have examined;

 

3.3that the Shares will be allotted and issued in the manner stated in the Plan;

 

3.4that the Company will receive consideration equal to the aggregate of the nominal value and any premium required to be paid up on the Shares issued pursuant to awards under the Plan and that such consideration will be in cash and/or otherwise provided in accordance with Irish law;

 

3.5that the filing of the Registration Statement with the SEC has been authorised by all necessary actions under all applicable laws other than Irish law;

 

3.6that the exercise of any options granted under the Plan and the issue of the Shares upon exercise of such options (and the issue of the Shares in connection with any other awards granted under the Plan) will be conducted in accordance with the terms and the procedures described in the Plan and the applicable award agreement;

 

3.7that the Company has sufficient share capital to issue the required number of Shares to be delivered to recipients of any awards granted under the Plan and the directors have sufficient authority pursuant to Section 1021 of the Act to issue such Shares, and to the extent applicable, have been authorised to issue such Shares without the application of pre-emption rights pursuant to Section 1023 of the Act;

 

3.8that where treasury shares are being re-issued, the maximum and minimum price of re-issue shall have been determined in advance at a general meeting of the Company in accordance with the requirements of Section 1078 of the Act;

 

3.9that the maximum number of Shares issued pursuant to awards granted under the Plan shall not exceed the amount authorized under the authority granted under Article 8(c) of the Constitution (the “Constitution Authorisation”) or any renewal or extension thereof when aggregated with all other Shares issued pursuant to or in reliance upon, as the case may be, the Constitution Authorisation or the applicable renewal or extension thereof;

 

3.10that the maximum number of Shares issued pursuant to awards granted under the Plan to persons that are not employees or former employees of the Company or any subsidiary of the Company shall not exceed the amount authorized under the Constitution Authorisation and any renewal or extension thereof when aggregated with all other Shares issued pursuant to or in reliance upon, as the case may be, the Constitution Authorisation or the applicable renewal or extension thereof;

 

3.11with respect to Shares issued pursuant to awards granted on or after the date of expiry of the Constitution Authorisation, the Company shall have renewed its authority to issue Shares and dis-apply pre-emption rights on the same terms as the Constitution Authorisation (modified only in respect of the extension of the expiry date), and such renewal or extension of the Constitution Authorisation shall be in effect at the time of such grant;

 

Page 3

 

 

 

 

Authenticity and bona fides

 

3.12the completeness and authenticity of all Documents submitted to us as originals or copies of originals (and in the case of copies, conformity to the originals of such copies), the genuineness of all signatories, stamps and seals thereon and where incomplete Documents have been submitted to us that the originals of such Documents are identical to the last draft of the complete Documents submitted to us;

 

3.13that the copies produced to us of minutes of meetings and/or of resolutions correctly record the proceedings at such meetings and/or the subject matter which they purport to record and that any meetings referred to in such copies were duly convened, duly quorate and held, that those present at any such meetings were entitled to attend and vote at the meeting and acted bona fide throughout and that no further resolutions have been passed or other action taken which would or might alter the effectiveness thereof;

 

3.14that there is, at the relevant time of the allotment and issue of the Shares, no matter affecting the authority of the directors to issue and allot the Shares, not disclosed by the Company’s constitution or the resolutions produced to us, which would have any adverse implications in relation to the opinions expressed in this Opinion;

 

3.15that the Constitution is the current Constitution, is up to date and has not been amended or superseded and that there are no other terms governing the Shares other than those set out in the Constitution;

 

Accuracy of searches and warranties

 

3.16the accuracy and completeness of the information disclosed in the searches referred to in paragraph 1.5 above and that such information has not since the time of such search or enquiry been altered. It should be noted that searches at the Companies Registration Office, Dublin, do not necessarily reveal whether or not a prior charge has been created or a resolution has been passed or a petition presented or any other action taken for the winding-up of or the appointment of a receiver or an examiner to the Company;

 

3.17the truth, completeness and accuracy of all representations and statements as to factual matters contained in the Documents; and

 

Commercial Benefit

 

3.18that the Documents have been entered into for bona fide commercial purposes, on arm’s length terms and for the benefit of each party thereto and are in those parties’ respective commercial interest and for their respective corporate benefit.

 

4.Disclosure

 

This Opinion is addressed to you in connection with the registration of the Shares with the SEC. We hereby consent to the inclusion of this Opinion as an exhibit to the Registration Statement. In giving this consent we do not thereby admit that we are in a category of person whose consent is required under Section 7 of the Securities Act.

 

The opinion is governed by and is to be construed in accordance with the laws of Ireland as interpreted by the courts of Ireland at the date hereof.

 

Page 4

 

 

 

 

Yours faithfully,

 

ARTHUR COX LLP

 

Page 5

 

 

 

 

SCHEDULE

 

The Documents

 

1.A copy of the Registration Statement to be filed by the Company with the SEC.

 

2.A copy of the Plan.

 

3.Copies of the resolutions of the board of directors of the Company dated 15 June 2022 and 16 June 2022 approving the Plan.

 

4.A certificate of the secretary of the Company dated on or about the date hereof, including extracts of the resolutions of the board of directors of the Company dated 15 June 2022 and 16 June 2022 regarding the approval of and adoption of, among other things, the Plan and all other matters contemplated thereby and the approval and filing of the Registration Statement with the SEC.

 

5.A copy of the Constitution of the Company effective on the date hereof, adopted pursuant to an Irish High Court order (the “Order”) following the Company’s examinership under Part 10 of the Act confirming a scheme of arrangement relating to the Company pursuant to Sections 541 and 542 of the Act (the “Scheme of Arrangement”)..

 

6.A copy of the Order and the Scheme of Arrangement.

 

7.A copy of the Certificate of Incorporation of the Company on registration as public limited company dated 9 January 2013 and the Company’s certificate of entitlement to do business dated 18 January 2013.

 

8.Letter of status from the Irish Companies Registration Office dated 1 July 2022.

 

Page 6